JUDY SPLITTGERBER: Open Payments
NPI 1003996646 · PRINCETON, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 24 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $86 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 8 | $180 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Novo Nordisk Inc | 3 | $51 |
| Alkermes, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: REXULTI, AUSTEDO XR, Rybelsus, CAPLYTA, ARISTADA, ROTATEQ, LYBALVI, MOUNJARO.
Industry payments across ME — which companies pay providers there.
